Prevalence of Breast fibroadenoma among patient attended breast clinic in Mosul district in Iraq

View at publisher Summarise with VIRAT
Authors: Dhafar Mahmood Omar
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: The most prominent benign tumor of the female breast is fibroadenoma. It is particularly prevalent among young women around the world. Objective(s): Identification of the most common risk factors for fibroadenoma among Iraqi women in the city of Mosul, which contributes to early classify women who are at high risk of developing breast cancer after being diagnosed with fibroadenoma. Method: The biometry study design was adopted from Jan 2020 to Dec 2020 from Al-Jamhoori and Al-Kansa hospitals in the city of Mosul where have been included 102 patients in this study. Cases were identified from biopsies examined at the two hospitals'' pathology departments and were included in the study only if the diagnosis was reconfirmed by the study pathologist. Results: Fibroadenoma was diagnosed at an average age of 32.6 years. Fibroadenoma (FA) was shown to increase the risk of participant characteristics considered to increase the risk of breast cancer with family history and higher education. Participants with established FA protective features (older age at menarche, more children) were shown to have a lower risk of fibroadenoma. Conclusion: We demonstrated that biopsy-confirmed fibroadenomas can be detected early. Biopsy confirmation of a fibroadenoma may be more prevalent more likely in older women, thus, caution is needed if the findings are to be applied to fibroadenomas diagnosed at a younger age.

Fields of Study & Subjects

Breast Lesions and Carcinomas Cancer Risks and Factors Breast Cancer Treatment Studies

Publication details

Journal / source
The Medical Journal of Tikrit University
Volume
27
Issue
2
Pages
1–10
Publication date
30 March 2026
Language
EN